Form 8-K - Current report:
SEC Accession No. 0001193125-24-219180
Filing Date
2024-09-16
Accepted
2024-09-16 06:43:01
Documents
61
Period of Report
2024-09-14
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d355136d8k.htm   iXBRL 8-K 32963
2 EX-99.1 d355136dex991.htm EX-99.1 29573
3 EX-99.2 d355136dex992.htm EX-99.2 49215
7 GRAPHIC g355136exas10g1.jpg GRAPHIC 116104
8 GRAPHIC g355136exas11g1.jpg GRAPHIC 147318
9 GRAPHIC g355136exas12g1.jpg GRAPHIC 104216
10 GRAPHIC g355136exas13g1.jpg GRAPHIC 103368
11 GRAPHIC g355136exas14g1.jpg GRAPHIC 97768
12 GRAPHIC g355136exas15g1.jpg GRAPHIC 126671
13 GRAPHIC g355136exas16g1.jpg GRAPHIC 83387
14 GRAPHIC g355136exas17g1.jpg GRAPHIC 108849
15 GRAPHIC g355136exas18g1.jpg GRAPHIC 102543
16 GRAPHIC g355136exas19g1.jpg GRAPHIC 82082
17 GRAPHIC g355136exas1g1.jpg GRAPHIC 71494
18 GRAPHIC g355136exas20g1.jpg GRAPHIC 105636
19 GRAPHIC g355136exas21g1.jpg GRAPHIC 100794
20 GRAPHIC g355136exas22g1.jpg GRAPHIC 107662
21 GRAPHIC g355136exas23g1.jpg GRAPHIC 150346
22 GRAPHIC g355136exas24g1.jpg GRAPHIC 116334
23 GRAPHIC g355136exas25g1.jpg GRAPHIC 92343
24 GRAPHIC g355136exas26g1.jpg GRAPHIC 106737
25 GRAPHIC g355136exas27g1.jpg GRAPHIC 62934
26 GRAPHIC g355136exas28g1.jpg GRAPHIC 120421
27 GRAPHIC g355136exas29g1.jpg GRAPHIC 156752
28 GRAPHIC g355136exas2g1.jpg GRAPHIC 185489
29 GRAPHIC g355136exas30g1.jpg GRAPHIC 103245
30 GRAPHIC g355136exas31g1.jpg GRAPHIC 120470
31 GRAPHIC g355136exas32g1.jpg GRAPHIC 109947
32 GRAPHIC g355136exas33g1.jpg GRAPHIC 95208
33 GRAPHIC g355136exas34g1.jpg GRAPHIC 113216
34 GRAPHIC g355136exas35g1.jpg GRAPHIC 109397
35 GRAPHIC g355136exas36g1.jpg GRAPHIC 93263
36 GRAPHIC g355136exas37g1.jpg GRAPHIC 122282
37 GRAPHIC g355136exas38g1.jpg GRAPHIC 78920
38 GRAPHIC g355136exas39g1.jpg GRAPHIC 97424
39 GRAPHIC g355136exas3g1.jpg GRAPHIC 60196
40 GRAPHIC g355136exas40g1.jpg GRAPHIC 93838
41 GRAPHIC g355136exas41g1.jpg GRAPHIC 74296
42 GRAPHIC g355136exas42g1.jpg GRAPHIC 51516
43 GRAPHIC g355136exas43g1.jpg GRAPHIC 123258
44 GRAPHIC g355136exas44g1.jpg GRAPHIC 58392
45 GRAPHIC g355136exas45g1.jpg GRAPHIC 23915
46 GRAPHIC g355136exas4g1.jpg GRAPHIC 109204
47 GRAPHIC g355136exas5g1.jpg GRAPHIC 110378
48 GRAPHIC g355136exas6g1.jpg GRAPHIC 125751
49 GRAPHIC g355136exas7g1.jpg GRAPHIC 128798
50 GRAPHIC g355136exas8g1.jpg GRAPHIC 93921
51 GRAPHIC g355136exas9g1.jpg GRAPHIC 121425
52 GRAPHIC g355136g0914230419526.jpg GRAPHIC 7597
  Complete submission text file 0001193125-24-219180.txt   6711153

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acrv-20240914.xsd EX-101.SCH 2839
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrv-20240914_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrv-20240914_pre.xml EX-101.PRE 11700
63 EXTRACTED XBRL INSTANCE DOCUMENT d355136d8k_htm.xml XML 3758
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Filer) CIK: 0001781174 (see all company filings)

EIN.: 825125532 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41551 | Film No.: 241299285
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)